1. Volume 145, Issue 1, Pages 166-175.e8 (July 2013)
Risk of Colorectal High-Grade Dysplasia and Cancer in a Prospective Observational Cohort of Patients With Inflammatory Bowel Disease 
Laurent Beaugerie, Magali Svrcek, Philippe Seksik, Anne–Marie Bouvier, Tabassome Simon, Matthieu Allez, Hedia Brixi, Jean–Marc Gornet, Romain Altwegg, Philippe Beau, Bernard Duclos, Arnaud Bourreille, Jean Faivre, Laurent Peyrin–Biroulet, Jean–François Fléjou, Fabrice Carrat 
Gastroenterology 
Volume 145, Issue 1, Pages e8 (July 2013)
DOI: /j.gastro
Copyright © 2013 AGA Institute Terms and Conditions

2. Figure 1
Incidence rates of colorectal HGD and cancer according to age at entry into the cohort in all IBD patients (A), IBD patients with long-standing extensive colitis (B), and IBD patients without long-standing extensive colitis (C).
Gastroenterology  , e8DOI: ( /j.gastro )
Copyright © 2013 AGA Institute Terms and Conditions

3. Figure 2
Probability of remaining free of colorectal advanced neoplasia (HGD or cancer) in patients with (A) or without (B) long-standing extensive colitis according to thiopurine exposure status at the time of entry into the cohort, and probability of remaining free of CRC in patients with (C) or without (D) long-standing extensive colitis according to thiopurine exposure status at the time of entry into the cohort.
Gastroenterology  , e8DOI: ( /j.gastro )
Copyright © 2013 AGA Institute Terms and Conditions

4. Figure 1
Incidence rates of colorectal advanced neoplasia grouped by IBD subtype at entry in the cohort. IBDU, inflammatory bowel disease, unclassified.
Gastroenterology  , e8DOI: ( /j.gastro )
Copyright © 2013 AGA Institute Terms and Conditions

5. Figure 2
Incidence rates of colorectal advanced neoplasia according to exposure to thiopurines at diagnosis of neoplasia and long-standing extensive colitis (LEC) status.
Gastroenterology  , e8DOI: ( /j.gastro )
Copyright © 2013 AGA Institute Terms and Conditions